Impact of Cardiac Resynchronization Therapy on Heart Transplant–Free Survival in Pediatric and Congenital Heart Disease Patients

Impact of Cardiac Resynchronization Therapy on Heart Transplant–Free Survival in Pediatric and Congenital Heart Disease Patients

Cardiac resynchronization therapy (CRT) studies in pediatric or congenital heart disease patients have shown an improvement in ejection fraction and heart failure symptoms. However, a survival benefit of CRT in this population has not been established. This study aimed to evaluate the impact of CRT...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation. Arrhythmia and electrophysiology 2020-04, Vol.13 (4), p.e007925-e007925, Article CIRCEP.119.007925
Hauptverfasser: Chubb, Henry, Rosenthal, David N., Almond, Christopher S., Ceresnak, Scott R., Motonaga, Kara S., Arunamata, Alisa A., Long, Jin, Trela, Anthony V., Hanisch, Debra, McElhinney, Doff B., Dubin, Anne M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cardiac resynchronization therapy (CRT) studies in pediatric or congenital heart disease patients have shown an improvement in ejection fraction and heart failure symptoms. However, a survival benefit of CRT in this population has not been established. This study aimed to evaluate the impact of CRT upon heart transplant-free survival in pediatric and congenital heart disease patients, using a propensity score-matched (PSM) analysis. This single-center study compared CRT patients (implant date, 2004-2017) and controls, matched by 1:1 PSM using 21 comprehensive baseline indices for risk stratification. CRT patients were
ISSN:1941-3084
1941-3149
1941-3084
DOI:10.1161/CIRCEP.119.007925